Health topic

Urinary Tract Infection Prevention

These are reviewed research connections, not a ranked list of remedies. An ingredient can appear here because evidence was uncertain, preclinical, or limited to a specific preparation and setting.

Ailment-to-evidence view

What the reviewed research points to

This order reflects the depth of the reviewed evidence, not which option works best or what anyone should take. Mixed and negative findings stay in the list because they can be more useful than a promising headline.

Deeper reviewed evidence Mixed or uncertain

Cranberry

The recurrent-UTI subgroup had a moderate-certainty benefit signal, while several other prespecified populations had null results and the products varied substantially.

Studied form
Cranberry juices, tablets, capsules, or powders; products and proanthocyanidin content were not interchangeable
Outcome
Prevention of symptomatic, culture-verified urinary tract infections in several at-risk populations
Evidence
Cochrane systematic review of 50 randomized or quasi-randomized studies
See the evidence and cautions →
How this order is calculated

Evidence syntheses come before individual randomized trials, which come before early human and preclinical work. Sample-size bands add a small amount. Positive, mixed, negative, and safety-only directions do not change the depth score. Study independence is not yet scored, so overlapping reviews must not be counted as separate confirmation.

Connected ingredients

What appears in the current evidence map

Source-linked records

1 reviewed record

Evidence synthesis Mixed or uncertain 50 studies with 8,857 randomized participants

Cranberry for UTI prevention: the population matters

This review found a preventive signal for women with recurrent UTIs, but not for every group. In the recurrent-UTI subgroup, cranberry products were linked to a lower risk of symptomatic, culture-confirmed infection. The same review found little or no benefit for institutionalized older adults, pregnant women, or adults with bladder-emptying problems. It studied prevention, not treatment of an infection that is already present.

What was studied
Cranberry juices, tablets, capsules, or powders; products and proanthocyanidin content were not interchangeable
Setting
Not an efficacy study
Why it ranks here
The recurrent-UTI subgroup had a moderate-certainty benefit signal, while several other prespecified populations had null results and the products varied substantially.
Limits and cautions
  • The pooled products included juices, tablets, capsules, and powders with uncertain equivalence.
  • The recurrent-UTI estimate came from eight studies and had moderate heterogeneity.
  • Pregnancy, institutionalized older adults, and neuromuscular bladder dysfunction had separate null findings and should not be merged with otherwise healthy women with recurrent UTIs.
  • The review does not support using cranberry to treat an existing UTI or delaying appropriate medical care.
  • Evidence was very uncertain on whether juice and tablets, or different proanthocyanidin doses, work differently.

This record covers prevention in defined populations. Painful urination, fever, flank pain, pregnancy, recurrent infection, or worsening symptoms can require prompt clinical assessment and should not be managed as a cranberry experiment.